Search Results - "Zerr I"

Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls.

Authors: Engel, K. Obst, K. Bandelow, B. et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Sep2016, Vol. 266 Issue 6, p557-566. 10p.

Subjects: Functional magnetic resonance imaging, Panic attacks, Panic disorders, Limbic system, Pathological physiology, Agoraphobia, Patients

Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt–Jakob disease.

Authors: Jacobi, C. Arlt, S. Reiber, H. et al.

Source: Acta Neurologica Scandinavica. Mar2005, Vol. 111 Issue 3, p185-190. 6p.

Subjects: Cerebrospinal fluid, Immunoglobulins, Creutzfeldt-Jakob disease, Central nervous system diseases, Varicella-zoster virus, Herpes simplex virus

Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).

Authors: Van Duijn, C.M. Delasnerie-Laupretre, N. Masullo, C. et al.

Source: Lancet. 4/11/1998, Vol. 351 Issue 9109, p1081-1085. 5p. 4 Charts.

Subjects: Creutzfeldt-Jakob disease, Bovine spongiform encephalopathy, Disease risk factors, Infectious disease transmission

Geographic Terms: Europe

Creutzfeldt–Jakob disease and oxidative stress.

Authors: Bleich, S. Kropp, S. Zerr, I. et al.

Source: Acta Neurologica Scandinavica. May2000, Vol. 101 Issue 5, p332-334. 3p.

Subjects: Creutzfeldt-Jakob disease, Photooxidative stress, Malondialdehyde

Zur Aufbereitung von Medizinprodukten unter besonderer Berücksichtigung der Creutzfeldt-JakobKrankheit und ihrer Variante: Eine Betrachtung 20 Jahre nach dem Bericht der deutschen Task Force vCJK.

Alternate Title: Reprocessing of medical devices with special reference to CreutzfeldtJakob disease and its variant: A review 20 years after the report of the German vCJD Task Force.

Authors: Beekes, M. Thanheiser, M. Zerr, I. et al.

Source: Zentralsterilisation. 2023, Vol. 31 Issue 3, p114-158. 30p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt−Jakob disease.

Authors: Gmitterová, K. Heinemann, U. Krasnianski, A. et al.

Source: European Journal of Neurology. Jun2016, Vol. 23 Issue 6, p1126-1133. 8p.

Subjects: Cerebrospinal fluid, Creutzfeldt-Jakob disease, Enolase, Cerebral amyloid angiopathy, Genotypes, Patients

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors: Zerr, I. Kallenberg, K. Summers, D. M. et al.

Source: Brain: A Journal of Neurology; Oct2009, Vol. 132 Issue 10, p2659-2668, 10p, 8 Charts

MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study.

Authors: Krasnianski, A. Kallenberg, K. Collie, D. A. et al.

Source: European Journal of Neurology. Aug2008, Vol. 15 Issue 8, p762-771. 10p. 2 Black and White Photographs, 4 Charts, 2 Graphs.

Subjects: Creutzfeldt-Jakob disease, Magnetic resonance imaging, Basal ganglia, Thalamus, Prions, Proteins

CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies.

Authors: Green, A. Sanchez-Juan, P. Ladogana, A. et al.

Source: European Journal of Neurology. Feb2007, Vol. 14 Issue 2, p121-124. 4p. 1 Chart.

Subjects: Neurological research, Creutzfeldt-Jakob disease, Cerebrospinal fluid, Chronic wasting disease, Leukocytes, Proteins, Patients

This result is not displayed to guests.
Login for full access.

Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease.

Authors: Alperovitch, A. Zerr, I. Pocchiari, M. et al.

Source: Lancet. 5/15/1999, Vol. 353 Issue 9165, p1673-1674. 2p. 1 Chart.

Apolipoprotein E in Creutzfeldt-Jakob disease.

Authors: Zerr, I Helmhold, M Armstrong, V W et al.

Source: Lancet. 1/7/1995, Vol. 345 Issue 8941, p68-69. 2p.

P2.028 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases

Authors: Zerr, I. Gawinecka, J. Gmitterowa, K.

Source: Parkinsonism & Related Disorders. Dec2009 Supplement 2, Vol. 15, pS96-S96. 1p.

Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases.

Authors: Llorens, F. Villar‐Piqué, A. Schmitz, M. et al.

Source: Neuropathology & Applied Neurobiology. Apr2020, Vol. 46 Issue 3, p240-254. 15p.

DNA versus RNA oxidation in Parkinson’s disease: Which is more important?

Authors: Gmitterová, K. Gawinecka, J. Heinemann, U. et al.

Source: Neuroscience Letters. Jan2018, Vol. 662, p22-28. 7p.

Cerebral microbleeds in early Alzheimer's disease.

Authors: Poliakova, T. Levin, O. Arablinskiy, A. et al.

Source: Journal of Neurology. Oct2016, Vol. 263 Issue 10, p1961-1968. 8p. 5 Charts, 3 Graphs.